Authors:
Easterling, TR
Carr, DB
Brateng, D
Diederichs, C
Schmucker, B
Citation: Tr. Easterling et al., Treatment of hypertension in pregnancy: Effect of atenolol on maternal disease, preterm delivery, and fetal growth, OBSTET GYN, 98(3), 2001, pp. 427-433
Authors:
Easterling, TR
Carr, DB
Davis, C
Diederichs, C
Brateng, DA
Schmucker, B
Citation: Tr. Easterling et al., Low-dose, short-acting, angiotensin-converting enzyme inhibitors as rescuetherapy in pregnancy, OBSTET GYN, 96(6), 2000, pp. 956-961
Citation: B. Schmucker et al., Novel alternatively spliced isoforms of the neurofibromatosis type 2 tumour suppressor are targeted to the nucleus and cytoplasmic granules (vol 8, 1561, 1999), HUM MOL GEN, 8(9), 1999, pp. 1817-1817
Citation: B. Schmucker et al., Novel alternatively spliced isoforms of the neurofibromatosis type 2 tumorsuppressor are targeted to the nucleus and cytoplasmic granules, HUM MOL GEN, 8(8), 1999, pp. 1561-1570
Citation: B. Schmucker et J. Seidel, Mosaicism for a full mutation and a normal size allele in two fragile X males, AM J MED G, 84(3), 1999, pp. 221-225
Authors:
Easterling, TR
Brateng, D
Schmucker, B
Brown, Z
Millard, SP
Citation: Tr. Easterling et al., Prevention of preeclampsia: A randomized trial of atenolol in hyperdynamicpatients before onset of hypertension, OBSTET GYN, 93(5), 1999, pp. 725-733